Neuroprotective molecular mechanisms of (−)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties

[1]  T. Cheng.  Green tea does not inhibit iron absorption. , 2009, International journal of cardiology.

[2]  E. Zenteno,et al.  Amyloid-β25–35 impairs memory and increases NO in the temporal cortex of rats , 2009, Neuroscience Research.

[3]  Jae Woong Lee,et al.  (−)-Epigallocatechin-3-gallate prevents lipopolysaccharide-induced elevation of beta-amyloid generation and memory deficiency , 2009, Brain Research.

[4]  Khadija Iqbal,et al.  Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease. , 2008, Current medicinal chemistry.

[5]  O. Shido,et al.  Green tea catechins prevent cognitive deficits caused by Abeta1-40 in rats. , 2008, The Journal of nutritional biochemistry.

[6]  Jen-kun Lin,et al.  Novel regimen through combination of memantine and tea polyphenol for neuroprotection against brain excitotoxicity , 2008, Journal of neuroscience research.

[7]  M. Youdim,et al.  The application of proteomics for studying the neurorescue activity of the polyphenol (-)-epigallocatechin-3-gallate. , 2008, Archives of biochemistry and biophysics.

[8]  E. Kua,et al.  Tea consumption and cognitive impairment and decline in older Chinese adults. , 2008, The American journal of clinical nutrition.

[9]  H. Hou,et al.  Green tea epigallocatechin-3-gallate (EGCG) reduces β-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice , 2008, Brain Research.

[10]  Anup A. Kale,et al.  Effect of nutrient mixture and black grapes on the pharmacokinetics of orally administered (‐)epigallocatechin‐3‐gallate from green tea extract: a human study , 2008, Phytotherapy research : PTR.

[11]  J. Spencer.  Flavonoids: modulators of brain function? , 2008, British Journal of Nutrition.

[12]  G. Rotilio,et al.  Benefits from Dietary Polyphenols for Brain Aging and Alzheimer’s Disease , 2008, Neurochemical Research.

[13]  P. Kalaiselvi,et al.  Attenuation of senescence-induced oxidative exacerbations in aged rat brain by (−)-epigallocatechin-3-gallate , 2008, International Journal of Developmental Neuroscience.

[14]  Jian-Min Yuan,et al.  Differential effects of black versus green tea on risk of Parkinson's disease in the Singapore Chinese Health Study. , 2007, American journal of epidemiology.

[15]  J. Spencer.  The interactions of flavonoids within neuronal signalling pathways , 2007, Genes & Nutrition.

[16]  M. Youdim,et al.  A novel approach of proteomics and transcriptomics to study the mechanism of action of the antioxidant-iron chelator green tea polyphenol (-)-epigallocatechin-3-gallate. , 2007, Free radical biology & medicine.

[17]  C. Rice-Evans,et al.  (‐)Epicatechin stimulates ERK‐dependent cyclic AMP response element activity and up‐regulates GluR2 in cortical neurons , 2007, Journal of neurochemistry.

[18]  R. Ratan,et al.  Hypoxia Inducible Factor Prolyl 4-Hydroxylase Enzymes: Center Stage in the Battle Against Hypoxia, Metabolic Compromise and Oxidative Stress , 2007, Neurochemical Research.

[19]  R. Tanzi,et al.  The 5′-untranslated region of Parkinson's disease α-synuclein messengerRNA contains a predicted iron responsive element , 2007, Molecular Psychiatry.

[20]  S. Mandel,et al.  Green tea polyphenol (–)‐epigallocatechin‐3‐gallate promotes the rapid protein kinase C‐ and proteasome‐mediated degradation of Bad: implications for neuroprotection , 2007, Journal of neurochemistry.

[21]  T. Tsai,et al.  Pharmacokinetics of (-)-epigallocatechin-3-gallate in conscious and freely moving rats and its brain regional distribution. , 2007, Journal of agricultural and food chemistry.

[22]  I. Grundke‐Iqbal,et al.  Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration , 2007, The European journal of neuroscience.

[23]  W. Le,et al.  Neuroprotective Effects of (-)-Epigallocatechin-3-gallate in a Transgenic Mouse Model of Amyotrophic Lateral Sclerosis , 2006, Neurochemical Research.

[24]  B. Sutherland,et al.  Mechanisms of action of green tea catechins, with a focus on ischemia-induced neurodegeneration. , 2006, The Journal of nutritional biochemistry.

[25]  Xudong Tang,et al.  Green tea extract and (−)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1α protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells , 2006, Molecular Cancer Therapeutics.

[26]  Reyes Artacho,et al.  Beneficial Effects of Green Tea—A Review , 2006, Journal of the American College of Nutrition.

[27]  S. Mandel,et al.  Reduction of iron‐regulated amyloid precursor protein and β‐amyloid peptide by (–)‐epigallocatechin‐3‐gallate in cell cultures: implications for iron chelation in Alzheimer's disease , 2006, Journal of neurochemistry.

[28]  Young Joo Lee,et al.  The effect of epigallocatechin gallate on suppressing disease progression of ALS model mice , 2006, Neuroscience Letters.

[29]  H. S. Scheuller,et al.  Catechin and caffeine content of green tea dietary supplements and correlation with antioxidant capacity. , 2006, Journal of agricultural and food chemistry.

[30]  R. Nagatomi,et al.  Green tea consumption and cognitive function: a cross-sectional study from the Tsurugaya Project 1. , 2006, The American journal of clinical nutrition.

[31]  J. LaManna,et al.  Hypoxia-inducible Factor Prolyl 4-Hydroxylase Inhibition , 2005, Journal of Biological Chemistry.

[32]  Francis C. Lau,et al.  The beneficial effects of fruit polyphenols on brain aging , 2005, Neurobiology of Aging.

[33]  R. Wenger,et al.  Induction of the hypoxia-inducible factor system by low levels of heat shock protein 90 inhibitors. , 2005, Cancer research.

[34]  David Morgan,et al.  Green Tea Epigallocatechin-3-Gallate (EGCG) Modulates Amyloid Precursor Protein Cleavage and Reduces Cerebral Amyloidosis in Alzheimer Transgenic Mice , 2005, The Journal of Neuroscience.

[35]  Rusha Thomas,et al.  Epigallocatechin gallate inhibits HIF-1α degradation in prostate cancer cells , 2005 .

[36]  S. Mandel,et al.  Green tea polyphenol (–)‐epigallocatechin‐3‐gallate induces neurorescue of long‐term serum‐deprived PC12 cells and promotes neurite outgrowth , 2005, Journal of neurochemistry.

[37]  S. Mandel,et al.  Multifunctional Activities of Green Tea Catechins in Neuroprotection , 2005, Neurosignals.

[38]  T. Gasiewicz,et al.  Epigallocatechin gallate inhibits aryl hydrocarbon receptor gene transcription through an indirect mechanism involving binding to a 90 kDa heat shock protein. , 2005, Biochemistry.

[39]  K. Pantopoulos,et al.  The pathway for IRP2 degradation involving 2-oxoglutarate-dependent oxygenase(s) does not require the E3 ubiquitin ligase activity of pVHL. , 2005, Biochimica et biophysica acta.

[40]  D. Jackson,et al.  Neuroprotective effects of (−)‐epigallocatechin gallate after hypoxia‐ischemia‐induced brain damage: novel mechanisms of action , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[41]  D. Ferreira,et al.  Hypoxia-inducible factor-1 activation by (-)-epicatechin gallate: potential adverse effects of cancer chemoprevention with high-dose green tea extracts. , 2004, Journal of natural products.

[42]  J. Kwak,et al.  Phospholipase C, protein kinase C, Ca2+/calmodulin-dependent protein kinase II, and redox state are involved in epigallocatechin gallate-induced phospholipase D activation in human astroglioma cells. , 2004, European journal of biochemistry.

[43]  S. Mandel,et al.  Neurological mechanisms of green tea polyphenols in Alzheimer's and Parkinson's diseases. , 2004, The Journal of nutritional biochemistry.

[44]  Myriam Bernaudin,et al.  HIF1 and oxygen sensing in the brain , 2004, Nature Reviews Neuroscience.

[45]  C. Rice-Evans,et al.  Flavonoids: antioxidants or signalling molecules? , 2004, Free radical biology & medicine.

[46]  S. Mandel,et al.  Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (‐)‐epigallocatechin‐3‐gallate: implications for neurodegenerative diseases , 2004, Journal of neurochemistry.

[47]  J. Jeong,et al.  Epigallocatechin 3-gallate attenuates neuronal damage induced by 3-hydroxykynurenine. , 2004, Toxicology.

[48]  H. Jung,et al.  Epigallocatechin gallate protects nerve growth factor differentiated PC12 cells from oxidative-radical-stress-induced apoptosis through its effect on phosphoinositide 3-kinase/Akt and glycogen synthase kinase-3. , 2003, Brain research. Molecular brain research.

[49]  Ji Hyun Han,et al.  Dual mechanisms of green tea extract‐induced cell survival in human epidermal keratinocytes , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[50]  A. Takashima,et al.  Potent anti‐amyloidogenic and fibril‐destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease , 2003, Journal of neurochemistry.

[51]  D. Berg,et al.  14-3-3 proteins in the nervous system , 2003, Nature Reviews Neuroscience.

[52]  S. Mandel,et al.  Gene and Protein Expression Profiles of Anti‐ and Pro‐apoptotic Actions of Dopamine, R‐Apomorphine, Green Tea Polyphenol (−)‐Epigallocatechine‐3‐gallate, and Melatonin , 2003, Annals of the New York Academy of Sciences.

[53]  Xiaofeng Meng,et al.  Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (-)-epigallocatechin gallate. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[54]  S. Mandel,et al.  cDNA gene expression profile homology of antioxidants and their antiapoptotic and proapoptotic activities in human neuroblastoma cells , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[55]  S. Mandel,et al.  Neuroprotection and neurorescue against Aβ toxicity and PKC‐dependent release of non‐amyloidogenic soluble precursor protein by green tea polyphenol (‐)‐epigallocatechin‐3‐gallate , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[56]  C. Rice-Evans,et al.  Interaction between flavonoids and the blood–brain barrier: in vitro studies , 2003, Journal of neurochemistry.

[57]  Jen-kun Lin,et al.  Factors affecting the levels of tea polyphenols and caffeine in tea leaves. , 2003, Journal of agricultural and food chemistry.

[58]  C. Pike,et al.  Estrogen activates protein kinase C in neurons: role in neuroprotection , 2003, Journal of neurochemistry.

[59]  S. Tsunenari,et al.  Inhibitory activity of epigallocatechin gallate (EGCg) in paraquat-induced microsomal lipid peroxidation--a mechanism of protective effects of EGCg against paraquat toxicity. , 2003, Toxicology.

[60]  Tianhong Pan,et al.  Effects of green tea polyphenols on dopamine uptake and on MPP+ -induced dopamine neuron injury. , 2003, Life sciences.

[61]  B. Frei,et al.  Tea Catechins and Polyphenols: Health Effects, Metabolism, and Antioxidant Functions , 2003, Critical reviews in food science and nutrition.

[62]  C. Rice-Evans,et al.  Uptake and metabolism of epicatechin and its access to the brain after oral ingestion. , 2002, Free radical biology & medicine.

[63]  Xudong Huang,et al.  An Iron-responsive Element Type II in the 5′-Untranslated Region of the Alzheimer's Amyloid Precursor Protein Transcript* , 2002, The Journal of Biological Chemistry.

[64]  Elizabeth C. Theil,et al.  Multiple, Conserved Iron-responsive Elements in the 3′-Untranslated Region of Transferrin Receptor mRNA Enhance Binding of Iron Regulatory Protein 2* , 2002, The Journal of Biological Chemistry.

[65]  C. Rice-Evans,et al.  MAPK signaling in neurodegeneration: influences of flavonoids and of nitric oxide , 2002, Neurobiology of Aging.

[66]  A. Kong,et al.  Antioxidants and oxidants regulated signal transduction pathways. , 2002, Biochemical pharmacology.

[67]  Yona Levites,et al.  Involvement of Protein Kinase C Activation and Cell Survival/ Cell Cycle Genes in Green Tea Polyphenol (−)-Epigallocatechin 3-Gallate Neuroprotective Action* , 2002, The Journal of Biological Chemistry.

[68]  J H Weisburger,et al.  Mechanisms of chronic disease causation by nutritional factors and tobacco products and their prevention by tea polyphenols. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[69]  Christine D Wu,et al.  Tea as a functional food for oral health. , 2002, Nutrition.

[70]  Harvey Checkoway,et al.  Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake. , 2002, American journal of epidemiology.

[71]  S. Suh,et al.  The green tea polyphenol (−)-epigallocatechin gallate attenuates β-amyloid-induced neurotoxicity in cultured hippocampal neurons , 2001 .

[72]  C. Rice-Evans,et al.  Bioavailability of flavan-3-ols and procyanidins: gastrointestinal tract influences and their relevance to bioactive forms in vivo. , 2001, Antioxidants & redox signaling.

[73]  S. Mandel,et al.  Green tea polyphenol (–)‐epigallocatechin‐3‐gallate prevents N‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced dopaminergic neurodegeneration , 2001, Journal of neurochemistry.

[74]  K. Senior.  New genes reveal major role for iron in neurodegeneration , 2001, The Lancet.

[75]  P. Maher.  How Protein Kinase C Activation Protects Nerve Cells from Oxidative Stress-Induced Cell Death , 2001, The Journal of Neuroscience.

[76]  Michael I. Wilson,et al.  Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation , 2001, Science.

[77]  S. Mandel,et al.  Effects of R- and S-apomorphine on MPTP-induced nigro-striatal dopamine neuronal loss. , 2001 .

[78]  M Gallorini,et al.  Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes , 2001, Journal of neurochemistry.

[79]  Y. Sagara,et al.  Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. , 2001, Free radical biology & medicine.

[80]  P A Insel,et al.  Protein kinase C isozymes and the regulation of diverse cell responses. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[81]  F. Kusu,et al.  Determination of catechins in human urine subsequent to tea ingestion by high-performance liquid chromatography with electrochemical detection. , 2000, Analytical biochemistry.

[82]  Yasuyoshi Watanabe,et al.  Neuroprotection by MAPK/ERK kinase inhibition with U0126 against oxidative stress in a mouse neuronal cell line and rat primary cultured cortical neurons , 2000, Neuroscience Letters.

[83]  David R Kaplan,et al.  Neurotrophin signal transduction in the nervous system , 2000, Current Opinion in Neurobiology.

[84]  C. Ho,et al.  Structural identification of two metabolites of catechins and their kinetics in human urine and blood after tea ingestion. , 2000, Chemical research in toxicology.

[85]  Jen-kun Lin,et al.  Suppression of lipopolysaccharide-induced nuclear factor-κB activity by theaflavin-3,3′-digallate from black tea and other polyphenols through down-regulation of IκB kinase activity in macrophages , 2000 .

[86]  M. Youdim,et al.  The Future of Neuroprotection , 1999, Annals of the New York Academy of Sciences.

[87]  G. Semenza,et al.  Protection from Oxidative Stress–Induced Apoptosis in Cortical Neuronal Cultures by Iron Chelators Is Associated with Enhanced DNA Binding of Hypoxia-Inducible Factor-1 and ATF-1/CREB and Increased Expression of Glycolytic Enzymes, p21waf1/cip1, and Erythropoietin , 1999, The Journal of Neuroscience.

[88]  F. Nanjo,et al.  Radical scavenging activity of tea catechins and their related compounds. , 1999, Bioscience, biotechnology, and biochemistry.

[89]  S. Mandel,et al.  Apomorphine protects against MPTP‐induced neurotoxicity in mice , 1999, Movement disorders : official journal of the Movement Disorder Society.

[90]  Y. Kan,et al.  Identification of the major antioxidative metabolites in biological fluids of the rat with ingested (+)-catechin and (-)-epicatechin. , 1999, Bioscience, biotechnology, and biochemistry.

[91]  D. Dorsa,et al.  The Mitogen-Activated Protein Kinase Pathway Mediates Estrogen Neuroprotection after Glutamate Toxicity in Primary Cortical Neurons , 1999, The Journal of Neuroscience.

[92]  E. Feskens,et al.  Tea flavonols in cardiovascular disease and cancer epidemiology. , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[93]  G. Yang,et al.  Inhibition of carcinogenesis by tea: bioavailability of tea polyphenols and mechanisms of actions. , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[94]  J. Hou,et al.  ESR study on the structure-antioxidant activity relationship of tea catechins and their epimers. , 1999, Biochimica et biophysica acta.

[95]  Y. L. Lin,et al.  Theaflavin-3,3'-digallate from black tea blocks the nitric oxide synthase by down-regulating the activation of NF-kappaB in macrophages. , 1999, European journal of pharmacology.

[96]  E. Hanson,et al.  Hypoxia Post-translationally Activates Iron-regulatory Protein 2* , 1999, The Journal of Biological Chemistry.

[97]  L. Hwang,et al.  The antioxidative property of green tea against iron-induced oxidative stress in rat brain. , 1998, The Chinese journal of physiology.

[98]  Fajun Yang,et al.  Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model. , 1998, The Journal of nutrition.

[99]  Hideyuki Ito,et al.  Wide distribution of [3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. , 1998, Carcinogenesis.

[100]  W. May,et al.  A Functional Role for Mitochondrial Protein Kinase Cα in Bcl2 Phosphorylation and Suppression of Apoptosis* , 1998, The Journal of Biological Chemistry.

[101]  M. Youdim,et al.  Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6‐Hydroxydopamine , 1998, Movement disorders : official journal of the Movement Disorder Society.

[102]  Z. Szallasi,et al.  Overexpression of Protein Kinase C Isoform but not δ in Human Interleukin-3–Dependent Cells Suppresses Apoptosis and Induces bcl-2 Expression , 1998 .

[103]  G. Binetti,et al.  Specific role for protein kinase Cα in the constitutive and regulated secretion of amyloid precursor protein in human skin fibroblasts , 1998, Neuroscience Letters.

[104]  S. Wiseman,et al.  Antioxidants in tea. , 1997, Critical reviews in food science and nutrition.

[105]  M. Chevion,et al.  Protective effects of tea polyphenols against oxidative damage to red blood cells. , 1997, Biochemical pharmacology.

[106]  Jen-kun Lin,et al.  (−)-Epigallocatechin-3-gallate Blocks the Induction of Nitric Oxide Synthase by Down-Regulating Lipopolysaccharide-Induced Activity of Transcription Factor Nuclear Factor-κB , 1997 .

[107]  Y Agid,et al.  Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[108]  Richard Mayeux,et al.  Diet and Parkinson's disease , 1997, Neurology.

[109]  K. Nakagawa,et al.  Chemiluminescence-high-performance liquid chromatographic determination of tea catechin, (-)-epigallocatechin 3-gallate, at picomole levels in rat and human plasma. , 1997, Analytical biochemistry.

[110]  C. Rice-Evans,et al.  Inhibition of peroxynitrite-mediated tyrosine nitration by catechin polyphenols. , 1997, Biochemical and biophysical research communications.

[111]  Q. Guo,et al.  Studies on protective mechanisms of four components of green tea polyphenols against lipid peroxidation in synaptosomes. , 1996, Biochimica et biophysica acta.

[112]  B. Halliwell.  Vitamin C: antioxidant or pro-oxidant in vivo? , 1996, Free radical research.

[113]  S. Sakaguchi,et al.  The Enhancing Effect of Tumour Necrosis Factor‐α on Oxidative Stress in Endotoxemia , 1996 .

[114]  A. Seidler,et al.  Diet and Parkinson's disease I , 1996, Neurology.

[115]  T. Taniguchi,et al.  Ca2+‐Dependent and Ca2+‐Independent Protein Kinase C Changes in the Brains of Patients with Alzheimer's Disease , 1996, Journal of neurochemistry.

[116]  Michael E. Greenberg,et al.  Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis , 1995, Science.

[117]  C. Rice-Evans,et al.  Polyphenolic flavanols as scavengers of aqueous phase radicals and as chain-breaking antioxidants. , 1995, Archives of biochemistry and biophysics.

[118]  R. Busto,et al.  Regional Alterations of Protein Kinase C Activity Following Transient Cerebral Ischemia: Effects of Intraischemic Brain Temperature Modulation , 1994, Journal of neurochemistry.

[119]  Minoru Harada,et al.  Tumor necrosis factor-α (TNF-α) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients , 1994, Neuroscience Letters.

[120]  F. Watt,et al.  Increased Iron in the Substantia Nigra Compacta of the MPTP‐Lesioned Hemiparkinsonian African Green Monkey: Evidence from Proton Microprobe Elemental Microanalysis , 1994, Journal of neurochemistry.

[121]  R. Wurtman,et al.  Regulation by phorbol esters of amyloid precursor protein release from Swiss 3T3 fibroblasts overexpressing protein kinase C alpha. , 1993, The Journal of biological chemistry.

[122]  T. Wieloch,et al.  Time Course of the Translocation and Inhibition of Protein kinase C During Complete Cerebral Ischemia in the Rat , 1993, Journal of neurochemistry.

[123]  G. Lescoat,et al.  Antioxidant and iron-chelating activities of the flavonoids catechin, quercetin and diosmetin on iron-loaded rat hepatocyte cultures. , 1993, Biochemical pharmacology.

[124]  Barry Halliwell,et al.  Reactive Oxygen Species and the Central Nervous System , 1992, Journal of neurochemistry.

[125]  H N Graham,et al.  Green tea composition, consumption, and polyphenol chemistry. , 1992, Preventive medicine.

[126]  P. Baeuerle,et al.  Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1. , 1991, The EMBO journal.

[127]  P Riederer,et al.  Selective Increase of Iron in Substantia Nigra Zona Compacta of Parkinsonian Brains , 1991, Journal of neurochemistry.

[128]  K. Jellinger,et al.  The implications of increased iron in parkinsonian substantia nigra and its high affinity binding to melanin for dopamine neuron degeneration , 1990 .

[129]  C. Winterbourn,et al.  6-Hydroxydopamine releases iron from ferritin and promotes ferritin-dependent lipid peroxidation. , 1989, Biochemical pharmacology.

[130]  Peter Riederer,et al.  Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains , 1989, Journal of neurochemistry.

[131]  M. Thompson,et al.  Stability of flavonoid complexes of copper(II) and flavonoid antioxidant activity. , 1976, Analytica chimica acta.

[132]  S. Mandel,et al.  Multifunctional neuroprotective derivatives of rasagiline as anti-alzheimer’s disease drugs , 2011, Neurotherapeutics.

[133]  Dongsun Park,et al.  Green tea extract increases cyclophosphamide-induced teratogenesis by modulating the expression of cytochrome P-450 mRNA. , 2009, Reproductive toxicology.

[134]  S. Mandel,et al.  Green tea polyphenol (−)-epigallocatechin-3-gallate protects rat PC12 cells from apoptosis induced by serum withdrawal , 2009, Neurotoxicity Research.

[135]  K. Choy,et al.  Uptake and distribution of catechins in fetal organs following in utero exposure in rats. , 2007, Human reproduction.

[136]  M. Youdim,et al.  Iron and α-synuclein in the substantia nigra of MPTP-treated mice , 2007, Journal of Molecular Neuroscience.

[137]  S. Mandel,et al.  Green tea catechins as brain-permeable, non toxic iron chelators to "iron out iron" from the brain. , 2006, Journal of neural transmission. Supplementum.

[138]  Xudong Tang,et al.  Green tea extract and (-)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1alpha protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells. , 2006, Molecular cancer therapeutics.

[139]  B. Stockwell,et al.  Multicomponent therapeutics for networked systems , 2005, Nature Reviews Drug Discovery.

[140]  Rusha Thomas,et al.  Epigallocatechin gallate inhibits HIF-1alpha degradation in prostate cancer cells. , 2005, Biochemical and biophysical research communications.

[141]  J. Satoh,et al.  The 14-3-3 Protein (cid:1) Isoform Expressed in Reactive Astrocytes in Demyelinating Lesions of Multiple Sclerosis Binds to Vimentin and Glial Fibrillary Acidic Protein in Cultured Human Astrocytes , 2004 .

[142]  Chi-Tang Ho,et al.  Green tea polyphenols , 2004 .

[143]  S. Mandel,et al.  Iron and alpha-synuclein in the substantia nigra of MPTP-treated mice: effect of neuroprotective drugs R-apomorphine and green tea polyphenol (-)-epigallocatechin-3-gallate. , 2004, Journal of molecular neuroscience : MN.

[144]  S. Mandel,et al.  Green tea polyphenol (-)-epigallocatechin-3-gallate protects rat PC12 cells from apoptosis induced by serum withdrawal independent of P13-Akt pathway. , 2003, Neurotoxicity research.

[145]  D. Deleu,et al.  Clinical Pharmacokinetic and Pharmacodynamic Properties of Drugs Used in the Treatment of Parkinson’s Disease , 2002, Clinical pharmacokinetics.

[146]  S. Mandel,et al.  Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-kappaB) activation and cell death by tea extracts in neuronal cultures. , 2002, Biochemical pharmacology.

[147]  Q. Guo,et al.  Free radical scavenging by green tea polyphenols. , 2001, Methods in enzymology.

[148]  R. Yu,et al.  Activation of antioxidant-response element (ARE), mitogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death , 2000, Archives of pharmacal research.

[149]  S. Lin-Shiau,et al.  Suppression of lipopolysaccharide-induced nuclear factor-kappaB activity by theaflavin-3,3'-digallate from black tea and other polyphenols through down-regulation of IkappaB kinase activity in macrophages. , 2000, Biochemical pharmacology.

[150]  N. Cairns,et al.  Increased levels of 14-3-3 gamma and epsilon proteins in brain of patients with Alzheimer's disease and Down syndrome. , 1999, Journal of neural transmission. Supplementum.

[151]  E. Leibold,et al.  Regulation of the iron regulatory proteins by reactive nitrogen and oxygen species. , 1999, Gene expression.

[152]  C. Gardana,et al.  Catechin metabolites after intake of green tea infusions , 1998, BioFactors.

[153]  Z. Szallasi,et al.  Overexpression of protein kinase C isoform epsilon but not delta in human interleukin-3-dependent cells suppresses apoptosis and induces bcl-2 expression. , 1998, Blood.

[154]  Y. L. Lin,et al.  (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kappaB. , 1997, Molecular pharmacology.

[155]  F. Nanjo,et al.  Scavenging effects of tea catechins and their derivatives on 1,1-diphenyl-2-picrylhydrazyl radical. , 1996, Free radical biology & medicine.

[156]  S A van Acker,et al.  Structural aspects of antioxidant activity of flavonoids. , 1996, Free radical biology & medicine.

[157]  S. Sakaguchi,et al.  The enhancing effect of tumour necrosis factor-alpha on oxidative stress in endotoxemia. , 1996, Pharmacology & toxicology.

[158]  P. Riederer,et al.  Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. , 1994, Neuroscience letters.

[159]  P. Riederer,et al.  Oxidative stress: free radical production in neural degeneration. , 1994, Pharmacology & therapeutics.

[160]  P. Riederer,et al.  Oxidative stress: a role in the pathogenesis of Parkinson's disease. , 1990, Journal of neural transmission. Supplementum.

[161]  K. Jellinger,et al.  Brain iron and ferritin in Parkinson's and Alzheimer's diseases , 1990, Journal of neural transmission. Parkinson's disease and dementia section.